HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 424 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $35,753,876 | +26.3% | 682,847 | -1.9% | 0.06% | +31.8% |
| Q1 2024 | $28,318,463 | +5.2% | 696,127 | -4.4% | 0.04% | -2.2% |
| Q4 2023 | $26,906,801 | -20.6% | 727,998 | -18.0% | 0.04% | -25.0% |
| Q3 2023 | $33,893,898 | +190.7% | 887,274 | +174.5% | 0.06% | +215.8% |
| Q2 2023 | $11,660,900 | +25.8% | 323,285 | +33.2% | 0.02% | +26.7% |
| Q1 2023 | $9,268,827 | -59.1% | 242,703 | -39.1% | 0.02% | -61.5% |
| Q4 2022 | $22,658,490 | -22.9% | 398,216 | -46.5% | 0.04% | -25.0% |
| Q3 2022 | $29,405,000 | +6.8% | 743,687 | +18.8% | 0.05% | +13.0% |
| Q2 2022 | $27,545,000 | -1.2% | 626,042 | -10.4% | 0.05% | +31.4% |
| Q1 2022 | $27,872,000 | -22.1% | 698,904 | -21.5% | 0.04% | -12.5% |
| Q4 2021 | $35,784,000 | – | 889,937 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $206,177,000 | 28.12% |
| BB BIOTECH AG | 8,322,860 | $121,763,000 | 3.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 398,633 | $4,579,000 | 2.84% |
| DOHENY ASSET MANAGEMENT /CA | 227,193 | $3,324,000 | 2.43% |
| SNYDER CAPITAL MANAGEMENT L P | 2,833,759 | $41,458,000 | 2.24% |
| First Light Asset Management, LLC | 938,399 | $13,729,000 | 2.19% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,027,164 | $132,067,000 | 1.77% |
| Taylor Wealth Management Partners | 204,277 | $2,989,000 | 1.72% |
| Sterling Global Strategies LLC | 22,000 | $321,860,000 | 1.63% |
| Granite Investment Partners, LLC | 988,939 | $14,468,000 | 1.06% |